172 related articles for article (PubMed ID: 32175414)
1. RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs and microRNAs.
Kuang P; Chen P; Wang L; Li W; Chen B; Liu Y; Xu Y; Wang H; Zhao S; Ye L; Yu F; Ji H; He Y
Ann Transl Med; 2020 Feb; 8(4):121. PubMed ID: 32175414
[TBL] [Abstract][Full Text] [Related]
2. Identification of lncRNA, miRNA and mRNA expression profiles and ceRNA Networks in small cell lung cancer.
Zhang C; Zhou Y; Zhang B; Sheng Z; Sun N; Yuan B; Wu X
BMC Genomics; 2023 Apr; 24(1):217. PubMed ID: 37098483
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation modifications reflect specific drug responses in small cell lung cancer.
Chen P; Guo H; Liu Y; Chen B; Zhao S; Wu S; Li W; Wang L; Jia K; Wang H; Jiang M; Tang X; Qi H; Dai C; Ye J; He Y
Genomics; 2021 May; 113(3):1114-1126. PubMed ID: 33705885
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study.
Zhang Y; Hao Y; Pan H; Zheng H; Zhou J
J Thorac Dis; 2023 Dec; 15(12):7013-7023. PubMed ID: 38249933
[TBL] [Abstract][Full Text] [Related]
5. mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung Cancer.
Chen P; Wu S; Yu J; Tang X; Dai C; Qi H; Zhu J; Li W; Chen B; Zhu J; Wang H; Zhao S; Liu H; Kuang P; He Y
J Healthc Eng; 2021; 2021():2105176. PubMed ID: 34621500
[TBL] [Abstract][Full Text] [Related]
6. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
7. Identification of alternative splicing and lncRNA genes in pathogenesis of small cell lung cancer based on their RNA sequencing.
Lei Y; Shi Y; Duan J; Liu Y; Lv G; Shi R; Zhang F; Yang Q; Zhao W
Adv Clin Exp Med; 2019 Aug; 28(8):1043-1050. PubMed ID: 31403267
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analyses of N
Luo Y; Zhang Z; Zheng B; Wu P; Zhang G; Wang L; Zeng Q; Yang Z; Xue L; Zeng H; Tan F; Xue Q; Gao S; Sun N; He J
Cancer Sci; 2022 Dec; 113(12):4289-4299. PubMed ID: 36047973
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omics Integration-Based Prioritisation of Competing Endogenous RNA Regulation Networks in Small Cell Lung Cancer: Molecular Characteristics and Drug Candidates.
Wang XJ; Gao J; Yu Q; Zhang M; Hu WD
Front Oncol; 2022; 12():904865. PubMed ID: 35860558
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNAs expression patterns associated with chemo response to cisplatin based chemotherapy in lung squamous cell carcinoma patients.
Hou Z; Xu C; Xie H; Xu H; Zhan P; Yu L; Fang X
PLoS One; 2014; 9(9):e108133. PubMed ID: 25250788
[TBL] [Abstract][Full Text] [Related]
12. Whole transcriptome analysis of HCT-8 cells infected by Cryptosporidium parvum.
Sun L; Li J; Xie F; Wu S; Shao T; Li X; Li J; Jian F; Zhang S; Ning C; Zhang L; Wang R
Parasit Vectors; 2022 Nov; 15(1):441. PubMed ID: 36434735
[TBL] [Abstract][Full Text] [Related]
13. Analysis of novel microRNA targets in drug-sensitive and -insensitive small cell lung cancer cell lines.
Ma L; Li P; Wang R; Nan Y; Liu X; Jin F
Oncol Rep; 2016 Mar; 35(3):1611-21. PubMed ID: 26676926
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.
Tanigawa K; Misono S; Mizuno K; Asai S; Suetsugu T; Uchida A; Kawano M; Inoue H; Seki N
Mol Oncol; 2023 Feb; 17(2):328-343. PubMed ID: 36345848
[TBL] [Abstract][Full Text] [Related]
15. The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases.
Leidinger P; Backes C; Blatt M; Keller A; Huwer H; Lepper P; Bals R; Meese E
Mol Cancer; 2014 Aug; 13():202. PubMed ID: 25175044
[TBL] [Abstract][Full Text] [Related]
16. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Xu Y; Chen J; Yang Z; Xu L
Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells.
Liu J; Yao Y; Huang J; Sun H; Pu Y; Tian M; Zheng M; He H; Li Z
BMC Genomics; 2022 Jun; 23(1):425. PubMed ID: 35672672
[TBL] [Abstract][Full Text] [Related]
18. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y
Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485
[TBL] [Abstract][Full Text] [Related]
19. Biological functions of long noncoding RNAs and circular RNAs in small-cell lung cancer.
Kumar S; Pandey M; Sharawat SK
Epigenomics; 2020 Oct; 12(19):1751-1763. PubMed ID: 33074037
[TBL] [Abstract][Full Text] [Related]
20. The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases.
Yao Q; Wang C; Wang Y; Zhang X; Jiang H; Chen D
Clin Transl Oncol; 2022 Dec; 24(12):2342-2350. PubMed ID: 35986859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
